Showing results (31-40 of 345) with videos related to
Sort By:
Pageof 35
Critical Reviews in Eukaryotic Gene Expression|August 4, 2012
Targeting the regulatory machinery of BIM for cancer therapyHisashi Harada, Steven GrantDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 26, 2003
The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapySteven Grant, John D RobertsExpert Opinion on Investigational Drugs|May 5, 2015
Romidepsin for the treatment of non-Hodgkin's lymphomaVictor Y Yazbeck, Steven GrantExpert Opinion on Investigational Drugs|December 19, 2003
Histone deacetylase inhibitors in clinical developmentRoberto R Rosato, Steven GrantMolecular Cancer Therapeutics|December 24, 2013
Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanismTri K Nguyen, Steven GrantPlos One|April 4, 2019
Intracellular invasion and survival of Brucella neotomae, another possible zoonotic Brucella speciesSteven Grant Waldrop, Nammalwar SriranganathanExpert Opinion on Therapeutic Targets|August 9, 2005
Histone deacetylase inhibitors: insights into mechanisms of lethalityRoberto R Rosato, Steven GrantCancer Biology & Therapy|April 4, 2003
Histone deacetylase inhibitors in cancer therapyRoberto R Rosato, Steven GrantExperimental Cell Research|June 14, 2002
The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated processMohamed Rahmani, Yun Dai, Steven GrantOncogene|October 17, 2003
Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent processYun Dai, Mohamed Rahmani, Steven GrantPageof 35